FSSAI advisory on Formalin (NOTIFICATIONS)
FSSAI advisory on Formalin
FSSAI advisory on Formalin (NOTIFICATIONS) Read More »
NOTIFICATIONS
Notification No. G.S.R. 411(E) dated 27/04/2018, regarding Manufacturing and Sale of Oxytocin (NOTIFICATIONS)
Notification No. G.S.R. 411(E) dated 27/04/2018, regarding Manufacturing and Sale of Oxytocin
Notification on perpetual validity of Drug licences (NOTIFICATIONS)
Notification on perpetual validity of Drug licences
Notification on perpetual validity of Drug licences (NOTIFICATIONS) Read More »
Notification S.O. 1851, 1852, 1853, 1854,& 1855. (NOTIFICATIONS)
Notification S.O. 1851, 1852, 1853, 1854,& 1855.
Notification S.O. 1851, 1852, 1853, 1854,& 1855. (NOTIFICATIONS) Read More »
Notification no GSR 328(E) dated 03/04/2017 (NOTIFICATIONS)
Notification no GSR 328(E) dated 03/04/2017
Notification no GSR 328(E) dated 03/04/2017 (NOTIFICATIONS) Read More »
Notification no GSR 367 (E) dated 13/04/2017 (NOTIFICATIONS)
Notification no GSR 367 (E) dated 13/04/2017
Notification no GSR 367 (E) dated 13/04/2017 (NOTIFICATIONS) Read More »
Final Notification on Compulsory submission of Bio equivalence Study Data (NOTIFICATIONS)
Final Notification on Compulsory submission of Bio equivalence Study Data
SUSPENSION OF MANUFACTURE FOR SALE , SALE AND DISTRIBUTION OF DEXTROPROPOXYPHENE AND ITS FORMULATIONS (NOTIFICATIONS)
SUSPENSION OF MANUFACTURE FOR SALE , SALE AND DISTRIBUTION OF DEXTROPROPOXYPHENE AND ITS FORMULATIONS
Revocation of the suspension of the notification G.S.R. No. 379(E) dated 18/06/2013 as regards to maufacture for sale, sale and distribution of Pioglitazone for human use (NOTIFICATIONS)
Revocation of the suspension of the notification G.S.R. No. 379(E) dated 18/06/2013 as regards to maufacture for sale, sale and distribution of Pioglitazone for human use
Revised Notification under Goa Public Health Amendment Act, 2005 (NOTIFICATIONS)
Revised Notification under Goa Public Health Amendment Act, 2005
Revised Notification under Goa Public Health Amendment Act, 2005 (NOTIFICATIONS) Read More »